Evidence map›Paper›PMID 18612770›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2008

The first Italian family with evidence of pyramidal impairment as phenotypic manifestation of Silver syndrome BSCL2 gene mutation.

Gianfranco Cafforio, Rosanna Calabrese, Nicola Morelli, Michelangelo Mancuso, Selina Piazza, Andrea Martinuzzi, Maria Teresa Bassi, Francesco Crippa, Gabriele Siciliano

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Gianfranco CafforioDepartment of Neuroscience O U of Neurology, S Chiara Hospital, University of Pisa, Pisa, Italy.
Rosanna Calabrese
Nicola Morelli
Michelangelo Mancuso
Selina Piazza
Andrea Martinuzzi
Maria Teresa Bassi
Francesco Crippa
Gabriele Siciliano
University of Pisa · ITIRCCS Eugenio Medea · ITAgenzia Regionale Sanitaria della Puglia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver syndrome (SPG17) is a rare form of hereditary spastic paraparesis. Its relationship to distal hereditary motor neuropathy (dHMN) type V is underlined by the recent discovery of causative mutation in BSCL2 gene coding for a protein termed seipin, an integral membrane protein of endoplasmic reticulum, with unknown function. Here we report the third Italian family with dHMN and SPG17 in which two affected members harbor the heterozygous N88S mutation in the BSCL2 gene. The proband developed a severe paraparetic spastic gait, while, in the other Italian families reported so far, no signs of upper motor neuron involvement were observed. This family confirms the clinical heterogeneity associated with this specific mutation. Moreover, this is the first report in which neuroimaging seems to confirm the pyramidal alterations in dHMN associated to SPG17.

Indexed as

AdultBrainDisease ProgressionDNA Mutational AnalysisFemaleGenetic MarkersGenetic Predisposition to DiseaseGenetic TestingGenotypeGTP-Binding Protein gamma SubunitsHereditary Sensory and Motor NeuropathyHeterozygoteHumansItalyMagnetic Resonance ImagingMaleBSCL2 protein, humanGenetic MarkersGTP-Binding Protein gamma Subunits

Identifiers

PMID18612770
OpenAlexW2032884637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.